175 related articles for article (PubMed ID: 19887544)
1. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
[TBL] [Abstract][Full Text] [Related]
2. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
3. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
4. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
5. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
[TBL] [Abstract][Full Text] [Related]
6. Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation.
Roberts HR; Smartt HJ; Greenhough A; Moore AE; Williams AC; Paraskeva C
Carcinogenesis; 2011 Nov; 32(11):1741-7. PubMed ID: 21926111
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.
Eruslanov E; Kaliberov S; Daurkin I; Kaliberova L; Buchsbaum D; Vieweg J; Kusmartsev S
J Immunol; 2009 Jun; 182(12):7548-57. PubMed ID: 19494278
[TBL] [Abstract][Full Text] [Related]
8. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
Kim HR; Lee HN; Lim K; Surh YJ; Na HK
Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
[TBL] [Abstract][Full Text] [Related]
11. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
[TBL] [Abstract][Full Text] [Related]
12. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y
J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883
[TBL] [Abstract][Full Text] [Related]
14. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
[TBL] [Abstract][Full Text] [Related]
15. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
17. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.
Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A
Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468
[TBL] [Abstract][Full Text] [Related]
18. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
[TBL] [Abstract][Full Text] [Related]
19. 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.
Pham H; Eibl G; Vincenti R; Chong B; Tai HH; Slice LW
Mol Carcinog; 2008 Jun; 47(6):466-77. PubMed ID: 18058808
[TBL] [Abstract][Full Text] [Related]
20. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
